ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,360Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 617

$501K Total Retail Price of All Prescriptions

Rank: 99 out of 617

599 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,022 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LISINOPRIL 519 468 1 5
AMLODIPINE BESYLATE 424 388 2 6
SIMVASTATIN 414 349 3 2
FUROSEMIDE 367 358 4 4
OMEPRAZOLE 350 300 5 3
HYDROCODONE-ACETAMINOPHEN 339 222 S3 6 8
LEVOTHYROXINE SODIUM 331 306 7 1
PRAVASTATIN SODIUM 322 316 8 21
METFORMIN HCL 300 256 9 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 261 245 10 29
WARFARIN SODIUM 236 223 11 7
CARVEDILOL 160 156 12 19
METOPROLOL TARTRATE 157 152 13 11
ZOLPIDEM TARTRATE 149 106 14 23
CITALOPRAM HBR 134 128 15 18
HYDROCHLOROTHIAZIDE 126 98 16 13
LOSARTAN POTASSIUM 126 114 16 22
ATORVASTATIN CALCIUM 125 115 18 14
TAMSULOSIN HCL 121 113 19 26
AZITHROMYCIN 114 108 20 70
SPIRONOLACTONE 112 112 21 42
FENTANYL 111 52 S2 22 45
LEVOFLOXACIN 103 92 23 89
AMOXICILLIN 103 90 23 135
DICLOFENAC SODIUM 103 88 23 98
METOPROLOL SUCCINATE 102 101 26 12
MELOXICAM 98 94 27 24
CIPROFLOXACIN HCL 95 89 28 60
ACETAMINOPHEN-CODEINE 94 89 S3 29 138
CRESTOR 88 84 30 28
TRAMADOL HCL 86 66 31 15
SYMBICORT 86 85 31 141
ISOSORBIDE MONONITRATE ER 83 80 33 52
LANTUS 81 75 34 39
POTASSIUM CHLORIDE 79 68 35 10
CELEBREX 78 78 36 63
CEFDINIR 76 57 37 169
ALLOPURINOL 76 69 37 27
ACTOS 75 65 39 85
GLIMEPIRIDE 72 39 40 33
GABAPENTIN 71 55 41 16
ADVAIR DISKUS 68 62 42 38
CYMBALTA 68 35 42 49
SERTRALINE HCL 66 63 44 20
DIGOXIN 64 64 45 48
POLYETHYLENE GLYCOL 3350 63 63 46 32
CEPHALEXIN 63 55 46 68
BENAZEPRIL HCL 62 55 48 44
TERAZOSIN HCL 59 58 49 96
ALBUTEROL SULFATE 58 58 50 112
PREDNISONE 58 58 50 31
BISOPROLOL FUMARATE 57 57 52 100
VESICARE 55 46 53 95
AMITRIPTYLINE HCL 53 39 R 54 56
ESCITALOPRAM OXALATE 53 53 54 65
BISOPROLOL-HYDROCHLOROTHIAZIDE 50 30 56 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.